✦ LIBER ✦

WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes

✍ Scribed by G. Marchesini; G. Forlani; F. Cerrelli; R. Manini; S. Natale; L. Baraldi; G. Ermini; G. Savorani; D. Zocchi; N. Melchionda

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of cardiovascular and total m

✍ G. T.-C. Ko; W.-Y. So; N. N. Chan; W.-B. Chan; P. C.-Y. Tong; J. Li; V. Yeung; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Pioglitazone in a subgroup of patients w

✍ J. William Lester; A.W. Fernandes 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

The NCEP-ATPIII but not the IDF criteria

✍ A. O. Y. Luk; R. C. W. Ma; W-Y. So; X-L. Yang; A. P. S. Kong; R. Ozaki; G. T. C. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Adiponectin, insulin resistance and clin

✍ Mojiminiyi, O A; Abdella, N A; Al Arouj, M; Ben Nakhi, A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

The International Diabetes Federation de

✍ G. Targher; L. Bertolini; R. Tessari; L. Zenari; G. Arcaro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Metabolic Surgery for the Treatment of T

✍ M. Fried; G. Ribaric; J. N. Buchwald; S. Svacina; K. Dolezalova; N. Scopinaro 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 273 KB